BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 15904894)

  • 1. Overexpression of calpastatin inhibits L8 myoblast fusion.
    Barnoy S; Maki M; Kosower NS
    Biochem Biophys Res Commun; 2005 Jul; 332(3):697-701. PubMed ID: 15904894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calpastatin in rat myoblasts: transient diminution and decreased phosphorylation depend on myogenin-directed myoblast differentiation.
    Barnoy S; Kosower NS
    Int J Biochem Cell Biol; 2007; 39(1):253-61. PubMed ID: 16997608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of calpain and calpastatin in differentiating myoblasts: mRNA levels, protein synthesis and stability.
    Barnoy S; Supino-Rosin L; Kosower NS
    Biochem J; 2000 Oct; 351 Pt 2(Pt 2):413-20. PubMed ID: 11023827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microinjection of calpastatin inhibits fusion in myoblasts.
    Temm-Grove CJ; Wert D; Thompson VF; Allen RE; Goll DE
    Exp Cell Res; 1999 Feb; 247(1):293-303. PubMed ID: 10047471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRPC1 regulates skeletal myoblast migration and differentiation.
    Louis M; Zanou N; Van Schoor M; Gailly P
    J Cell Sci; 2008 Dec; 121(Pt 23):3951-9. PubMed ID: 19001499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The calpain-calpastatin system and protein degradation in fusing myoblasts.
    Barnoy S; Glaser T; Kosower NS
    Biochim Biophys Acta; 1998 Mar; 1402(1):52-60. PubMed ID: 9551085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of calpastatin (the specific calpain inhibitor) in myoblast differentiation and fusion.
    Barnoy S; Glasner T; Kosower NS
    Biochem Biophys Res Commun; 1996 Mar; 220(3):933-8. PubMed ID: 8607870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caspase-1-induced calpastatin degradation in myoblast differentiation and fusion: cross-talk between the caspase and calpain systems.
    Barnoy S; Kosower NS
    FEBS Lett; 2003 Jul; 546(2-3):213-7. PubMed ID: 12832042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calpain and calpastatin in myoblast differentiation and fusion: effects of inhibitors.
    Barnoy S; Glaser T; Kosower NS
    Biochim Biophys Acta; 1997 Sep; 1358(2):181-8. PubMed ID: 9332454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calpastatin-modulation of m-calpain activity is required for myoblast fusion.
    Balcerzak D; Cottin P; Poussard S; Cucuron A; Brustis JJ; Ducastaing A
    Eur J Cell Biol; 1998 Mar; 75(3):247-53. PubMed ID: 9587056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calpastatin overexpression attenuates amyloid-beta-peptide toxicity in differentiated PC12 cells.
    Vaisid T; Barnoy S; Kosower NS
    Neuroscience; 2008 Oct; 156(4):921-31. PubMed ID: 18786620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of mu- and m-calpains and protein kinase C isoforms in L8 myoblast differentiation.
    Liang YC; Yeh JY; Forsberg NE; Ou BR
    Int J Biochem Cell Biol; 2006; 38(4):662-70. PubMed ID: 16387524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rat myoblast fusion requires exteriorized m-calpain activity.
    Brustis JJ; Elamrani N; Balcerzak D; Safwate A; Soriano M; Poussard S; Cottin P; Ducastaing A
    Eur J Cell Biol; 1994 Aug; 64(2):320-7. PubMed ID: 7813519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERK2 is required for efficient terminal differentiation of skeletal myoblasts.
    Li J; Johnson SE
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1425-33. PubMed ID: 16729973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myoblast attachment and spreading are regulated by different patterns by ubiquitous calpains.
    Mazères G; Leloup L; Daury L; Cottin P; Brustis JJ
    Cell Motil Cytoskeleton; 2006 Apr; 63(4):193-207. PubMed ID: 16496301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel glycosaminoglycan mimetic (RGTA, RGD120) contributes to enhance skeletal muscle satellite cell fusion by increasing intracellular Ca2+ and calpain activity.
    Zimowska M; Constantin B; Papy-Garcia D; Raymond G; Cognard C; Caruelle JP; Moraczewski J; Martelly I
    J Cell Physiol; 2005 Nov; 205(2):237-45. PubMed ID: 15887234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pitx2c overexpression promotes cell proliferation and arrests differentiation in myoblasts.
    Martínez-Fernandez S; Hernández-Torres F; Franco D; Lyons GE; Navarro F; Aránega AE
    Dev Dyn; 2006 Nov; 235(11):2930-9. PubMed ID: 16958127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wild-type myoblasts rescue the ability of myogenin-null myoblasts to fuse in vivo.
    Myer A; Wagner DS; Vivian JL; Olson EN; Klein WH
    Dev Biol; 1997 May; 185(2):127-38. PubMed ID: 9187078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RhoE controls myoblast alignment prior fusion through RhoA and ROCK.
    Fortier M; Comunale F; Kucharczak J; Blangy A; Charrasse S; Gauthier-Rouvière C
    Cell Death Differ; 2008 Aug; 15(8):1221-31. PubMed ID: 18369372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AP-2 alpha suppresses skeletal myoblast proliferation and represses fibroblast growth factor receptor 1 promoter activity.
    Mitchell DL; DiMario JX
    Exp Cell Res; 2010 Jan; 316(2):194-202. PubMed ID: 19699737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.